Literature DB >> 30956595

Multiple cutaneous and mucosal lesions in a patient with cocaine-levamisole-induced vasculopathy syndrome.

Arianne Clare Agdamag1, Ofelya Gevorgyan2, Michael Lawrenz Co1, Sobia Hassan2.   

Abstract

Levamisole is an adulterant found in nearly 70% of cocaine in the United States. The concomitant use of levamisole and cocaine leads to a distinct clinical syndrome that typically manifests as agranulocytosis, leukocytoclastic vasculitis, and elevated antineutrophil cytoplasmic antibody (ANCA) levels. Systemic involvement has also been rarely reported with this syndrome. This is a case of a 51-year-old woman with chronic cocaine use who initially presented with multiple cutaneous ulcerations and was later found to have pulmonary and renal involvement. Infectious workup was unrevealing and autoimmune workup revealed highly elevated levels of perinuclear ANCA. Due to continuous cocaine use despite counseling, the patient was readmitted with worsening pulmonary and renal manifestations requiring initiation of immunosuppressive therapy.

Entities:  

Keywords:  ANCA antibody; cocaine; cocaine-levamisole vasculitis; levamisole

Year:  2018        PMID: 30956595      PMCID: PMC6442899          DOI: 10.1080/08998280.2018.1503478

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  11 in total

1.  Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association.

Authors:  Michael R Jaff; M Sean McMurtry; Stephen L Archer; Mary Cushman; Neil Goldenberg; Samuel Z Goldhaber; J Stephen Jenkins; Jeffrey A Kline; Andrew D Michaels; Patricia Thistlethwaite; Suresh Vedantham; R James White; Brenda K Zierler
Journal:  Circulation       Date:  2011-03-21       Impact factor: 29.690

2.  2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.

Authors:  Stavros V Konstantinides; Adam Torbicki; Giancarlo Agnelli; Nicolas Danchin; David Fitzmaurice; Nazzareno Galiè; J Simon R Gibbs; Menno V Huisman; Marc Humbert; Nils Kucher; Irene Lang; Mareike Lankeit; John Lekakis; Christoph Maack; Eckhard Mayer; Nicolas Meneveau; Arnaud Perrier; Piotr Pruszczyk; Lars H Rasmussen; Thomas H Schindler; Pavel Svitil; Anton Vonk Noordegraaf; Jose Luis Zamorano; Maurizio Zompatori
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

Review 3.  Predictive Value of Computed Tomography in Acute Pulmonary Embolism: Systematic Review and Meta-analysis.

Authors:  Felix G Meinel; John W Nance; U Joseph Schoepf; Verena S Hoffmann; Kolja M Thierfelder; Philip Costello; Samuel Z Goldhaber; Fabian Bamberg
Journal:  Am J Med       Date:  2015-02-11       Impact factor: 4.965

4.  Fibrinolysis for patients with intermediate-risk pulmonary embolism.

Authors:  Guy Meyer; Eric Vicaut; Thierry Danays; Giancarlo Agnelli; Cecilia Becattini; Jan Beyer-Westendorf; Erich Bluhmki; Helene Bouvaist; Benjamin Brenner; Francis Couturaud; Claudia Dellas; Klaus Empen; Ana Franca; Nazzareno Galiè; Annette Geibel; Samuel Z Goldhaber; David Jimenez; Matija Kozak; Christian Kupatt; Nils Kucher; Irene M Lang; Mareike Lankeit; Nicolas Meneveau; Gerard Pacouret; Massimiliano Palazzini; Antoniu Petris; Piotr Pruszczyk; Matteo Rugolotto; Aldo Salvi; Sebastian Schellong; Mustapha Sebbane; Bozena Sobkowicz; Branislav S Stefanovic; Holger Thiele; Adam Torbicki; Franck Verschuren; Stavros V Konstantinides
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

5.  Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

Authors:  Clive Kearon; Elie A Akl; Joseph Ornelas; Allen Blaivas; David Jimenez; Henri Bounameaux; Menno Huisman; Christopher S King; Timothy A Morris; Namita Sood; Scott M Stevens; Janine R E Vintch; Philip Wells; Scott C Woller; Lisa Moores
Journal:  Chest       Date:  2016-01-07       Impact factor: 9.410

6.  Time trends in pulmonary embolism in the United States: evidence of overdiagnosis.

Authors:  Renda Soylemez Wiener; Lisa M Schwartz; Steven Woloshin
Journal:  Arch Intern Med       Date:  2011-05-09

Review 7.  Pulmonary Embolism Response Teams.

Authors:  Alison S Witkin; Savanah Harshbarger; Christopher Kabrhel
Journal:  Semin Thromb Hemost       Date:  2016-10-21       Impact factor: 4.180

8.  Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry).

Authors:  Charles V Pollack; Donald Schreiber; Samuel Z Goldhaber; David Slattery; John Fanikos; Brian J O'Neil; James R Thompson; Brian Hiestand; Beau A Briese; Robert C Pendleton; Chadwick D Miller; Jeffrey A Kline
Journal:  J Am Coll Cardiol       Date:  2011-02-08       Impact factor: 24.094

9.  Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism.

Authors:  David Jiménez; Drahomir Aujesky; Lisa Moores; Vicente Gómez; José Luis Lobo; Fernando Uresandi; Remedios Otero; Manuel Monreal; Alfonso Muriel; Roger D Yusen
Journal:  Arch Intern Med       Date:  2010-08-09

10.  Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis.

Authors:  Saurav Chatterjee; Anasua Chakraborty; Ido Weinberg; Mitul Kadakia; Robert L Wilensky; Partha Sardar; Dharam J Kumbhani; Debabrata Mukherjee; Michael R Jaff; Jay Giri
Journal:  JAMA       Date:  2014-06-18       Impact factor: 56.272

View more
  1 in total

1.  Cocaine/Levamisole-Induced, Skin-Limited ANCA-Associated Vasculitis with Pyoderma Gangrenosum-like Presentation.

Authors:  Mirjana Urosevic-Maiwald; Jan-Hendrik B Hardenberg; Jürg Hafner; Marie-Charlotte Brüggen
Journal:  Dermatopathology (Basel)       Date:  2022-06-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.